Search research articles
Contact Us
Filters
Showing results (181-190 of 332) with videos related to
Page
of 34
Sort By:
Journal of Neuroscience Methods
|
July 9, 2009
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors
David Tweedie, Weiming Luo, Ryan G Short, et al.
Plos One
|
December 7, 2013
Cognitive impairments accompanying rodent mild traumatic brain injury involve p53-dependent neuronal cell death and are ameliorated by the tetrahydrobenzothiazole PFT-α
Lital Rachmany, David Tweedie, Vardit Rubovitch, et al.
CNS & Neurological Disorders Drug Targets
|
May 16, 2012
Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase
Medha Priyadarshini, Mohammad A Kamal, Nigel H Greig, et al.
Frontiers in Pharmacology
|
January 26, 2026
Pharmacological characterization and preclinical evaluation of 11h: a novel, brain-penetrant PDE4 inhibitor for neurological disorders
Jacob Lackovic, Sougata Dey, Sara Jane Ward, et al.
Current Drug Targets
|
July 24, 2004
Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors
Kumar Sambamurti, Ann-Charlotte Granholm, Mark S Kindy, et al.
Journal of Neurochemistry
|
July 12, 2011
Tumor necrosis factor-α synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice
Renana Baratz, David Tweedie, Vardit Rubovitch, et al.
Plos One
|
May 7, 2019
Is insulin resistance the cause of fibromyalgia? A preliminary report
Miguel A Pappolla, Laxmaiah Manchikanti, Clark R Andersen, et al.
Current Alzheimer Research
|
October 27, 2005
Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects
Nigel H Greig, Jon Ruckle, Patrick Comer, et al.
Elife
|
August 18, 2020
Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury
David Tweedie, Hanuma Kumar Karnati, Roger Mullins, et al.
Journal of Neuroscience Methods
|
February 13, 2016
Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development
Hanna Deselms, Nicola Maggio, Vardit Rubovitch, et al.
Page
of 34
Search research articles
Search
Showing results (181-190 of 332) with videos related to
Sort By:
Page
of 34
Journal of Neuroscience Methods
|
July 9, 2009
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors
David Tweedie, Weiming Luo, Ryan G Short, et al.
Plos One
|
December 7, 2013
Cognitive impairments accompanying rodent mild traumatic brain injury involve p53-dependent neuronal cell death and are ameliorated by the tetrahydrobenzothiazole PFT-α
Lital Rachmany, David Tweedie, Vardit Rubovitch, et al.
CNS & Neurological Disorders Drug Targets
|
May 16, 2012
Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase
Medha Priyadarshini, Mohammad A Kamal, Nigel H Greig, et al.
Frontiers in Pharmacology
|
January 26, 2026
Pharmacological characterization and preclinical evaluation of 11h: a novel, brain-penetrant PDE4 inhibitor for neurological disorders
Jacob Lackovic, Sougata Dey, Sara Jane Ward, et al.
Current Drug Targets
|
July 24, 2004
Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors
Kumar Sambamurti, Ann-Charlotte Granholm, Mark S Kindy, et al.
Journal of Neurochemistry
|
July 12, 2011
Tumor necrosis factor-α synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice
Renana Baratz, David Tweedie, Vardit Rubovitch, et al.
Plos One
|
May 7, 2019
Is insulin resistance the cause of fibromyalgia? A preliminary report
Miguel A Pappolla, Laxmaiah Manchikanti, Clark R Andersen, et al.
Current Alzheimer Research
|
October 27, 2005
Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects
Nigel H Greig, Jon Ruckle, Patrick Comer, et al.
Elife
|
August 18, 2020
Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury
David Tweedie, Hanuma Kumar Karnati, Roger Mullins, et al.
Journal of Neuroscience Methods
|
February 13, 2016
Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development
Hanna Deselms, Nicola Maggio, Vardit Rubovitch, et al.
Page
of 34